Lifshitz Law Firm, P.C. Announces Investigations of Bristol-Myers Squibb Company , Eargo, Inc. , Hyzon Motors Inc. , Nano-X Imaging Ltd. , and View, Inc. Pharmaceutical Investing
Gilead Announces New England Journal of Medicine Publication of Data Demonstrating Veklury® Significantly Reduced Risk of Hospitalization in High-Risk Patients With COVID-19 Pharmaceutical Investing
Boosh Currently Onboarding 25 New Accounts Per Month; Update On Sales Performance Life Science Investing
Gilead Announces Clinical Hold on Studies Evaluating Injectable Lenacapavir for HIV Treatment and Prevention Due to Vial Quality Concerns Pharmaceutical Investing
Gilead and Arcus Biosciences Complete Closing of Option Exercise for Three Clinical-Stage Programs and New Research Collaboration Pharmaceutical Investing
European Commission Expands Indication for Veklury for the Treatment of Adults Not on Supplemental Oxygen and Considered High Risk for COVID-19 Disease Progression Pharmaceutical Investing
FDA APPROVES OTEZLA® FOR THE TREATMENT OF ADULT PATIENTS WITH PLAQUE PSORIASIS, REGARDLESS OF SEVERITY LEVEL Market News
Sirona Biochem Antiviral Compounds to be Tested Against SARS-CoV-2 by Top US Testing Facility Life Science Investing
